MENU
LYRA
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Lyra Therapeutics (LYRA) Ownership - Who owns Lyra Therapeutics?

Lyra Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of anti-inflammatory therapies for the localized treatment of patients with chronic rhinosinusitis, or CRS... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
354.98K
P/E Ratio
N/A
Total Cash
22.06M
Projected Growth
N/A
Total Debt
31.38M
Revenue
600K
Risk (Beta)
2.61
Dividend Yield
N/A
Total Cash/Share
12.43
Total Debt/Equity
N/A
Revenue/Share
0.26 USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage therapeutics company, which develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases

Industry Biotechnology

Profile
Details
Who owns Lyra Therapeutics? LYRA symbol Ownership - Tickeron.com